The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.
Open accessAbstract
Mice injected with anti-Fas antibody die within a few hours with total liver destruction due to massive apoptosis of hepatocytes. We show that this is preceded and accompanied by the sequential activation of cysteine proteases of the interleukin 1 beta-converting enzyme (ICE) and CPP32 types in the cytosol of the hepatocytes, and that proCPP32 cleavage and enzymatic activity can be prevented by intravenous injections of the tripeptide N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD.fmk), an inhibitor of ICE-like proteases. Four Z-VAD.fmk injections at 1-hour intervals abolished all signs of liver damage after anti-Fas antibody injection and resulted in 100% long-range recovery, without residual tissue damage, from a condition otherwise uniformly fatal within < 3 hours. This treatment was effective even when delayed until some liver DNA degradation was already detectable. Injections of the tetrapeptide Ac-YVAD.cmk, more specific for the ICE-like subfamily of cysteine proteases but less cell permeable, also gave protection, but at higher doses and when injections started before that of anti-Fas antibody. These observations afford a way of temporarily modulating a number of apoptotic processes in vivo and may have important therapeutic implications in some human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · cited 2×
“However , the first element o f the cascade in Fas-induced P C D is the activation o f the M A C H FLICE cysteine protease, bound to the M O R T ( F A D D ) Fas protein complex (10, 11).”
BackgroundA novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,562
Yuan, J. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,483
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Self-citationFas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Self-citationMiura, M. (1993) · Cell · doi:10.1016/0092-8674(93)90486-a · Cited by 1,373
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
Enari, M., Talanian, R. V., Wrong, W. W., & Nagata, S. (1996) · Nature · doi:10.1038/380723a0 · Cited by 964
Self-citationWong, G. H. W., Elwell, J. H., Oberley, L. W., & Goeddel, D. V. (1989) · Cell · doi:10.1016/0092-8674(89)90944-6 · Cited by 802
Involvement of an ICE-like protease in Fas-mediated apoptosis
Enari, M., Hug, H., & Nagata, S. (1995) · Nature · doi:10.1038/375078a0 · Cited by 734
Self-citationActivation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
Darmon, A. J., Nicholson, D. W., & Bleackley, R. C. (1995) · Nature · doi:10.1038/377446a0 · Cited by 707
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
SLEE, E. A., ZHU, H., CHOW, S. C., MacFARLANE, M., NICHOLSON, D. W., & COHEN, G. M. (1996) · Biochemical Journal · doi:10.1042/bj3150021 · Cited by 496
Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.
Jacobsen, M. D., Weil, M., & Raff, M. C. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1041 · Cited by 367
M. Chinnaiyan, A., & Dixit, V. M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00541-9 · Cited by 347
Duan, H., Chinnaiyan, A. M., Hudson, P. L., Wing, J. P., He, W.-W., & Dixit, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1621 · Cited by 321
Milligan, C. E., Prevette, D., Yaginuma, H., Homma, S., Cardwellt, C., Fritz, L. C., Tomaselli, K. J., Oppenheim, R. W., & Schwartz, L. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90042-x · Cited by 313
Martin, S. J., Amarante-Mendes, G. P., Shi, L., Chuang, T. H., Casiano, C. A., O'Brien, G. A., Fitzgerald, P., Tan, E. M., Bokoch, G. M., Greenberg, A. H., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00598.x · Cited by 276
ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis
Nicholson, D. W. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-297 · Cited by 265
Inactivation of Interleukin-1.beta. Converting Enzyme by Peptide (Acyloxy)methyl Ketones
Thornberry, N. A., Peterson, E. P., Zhao, J. J., Howard, A. D., Griffin, P. R., & Chapman, K. T. (1994) · Biochemistry · doi:10.1021/bi00179a020 · Cited by 265
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B.
Quan, L. T., Tewari, M., O'Rourke, K., Dixit, V, Snipas, S. J., Poirier, G. G., Ray, C., Pickup, D. J., & Salvesen, G. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1972 · Cited by 172
Dolle, R. E., Hoyer, D., Prasad, C. V. C., Schmidt, S. J., Helaszek, C. T., Miller, R. E., & Ator, M. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a003 · Cited by 143
Ramage, P., Cheneval, D., Chvei, M., Graff, P., Hemmig, R., Heng, R., Kocher, H. P., MacKenzie, A. R., Memmert, K., Révész, L., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9378 · Cited by 109
Liu, X., Kim, C. N., Pohl, J., & Wang, X. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13371 · Cited by 85
Cited by
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Self-citationCaspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 977
Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1477 · Cited by 922
Metadata
- Authors
- Rodriguez, I., Matsuura, K., Ody, C., Nagata, S., & Vassalli, P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-11-01
- Volume
- 184
- Issue
- 5
- Pages
- 2067-2072
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2132024844
- Cited by
- 269
- References
- 26
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.